Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000474849 | SCV000548931 | likely benign | Adams-Oliver syndrome 5 | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313168 | SCV000739385 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-03-03 | criteria provided, single submitter | clinical testing | The p.R2313Q variant (also known as c.6938G>A), located in coding exon 34 of the NOTCH1 gene, results from a G to A substitution at nucleotide position 6938. The arginine at codon 2313 is replaced by glutamine, an amino acid with highly similar properties. This alteration was reported in an individual with hypoplastic left heart syndrome and classified as variant of unknown significance (Kerstjens-Frederikse WS et al. Genet. Med., 2016 Sep;18:914-23). This amino acid position is well conserved in available vertebrate species; however, glutamine is the reference amino acid in other vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV001546211 | SCV001765690 | uncertain significance | not provided | 2024-12-19 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32361481, 26820064) |
Molecular Genetics, |
RCV003993971 | SCV004812741 | uncertain significance | Aortic valve disease 1 | 2023-09-04 | criteria provided, single submitter | clinical testing |